As of 2025-05-17, the Intrinsic Value of Sumitomo Dainippon Pharma Co Ltd (4506.T) is (41,229.71) JPY. This 4506.T valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 833.00 JPY, the upside of Sumitomo Dainippon Pharma Co Ltd is -5,049.50%.
The range of the Intrinsic Value is (265,628.09) - (22,952.50) JPY
Based on its market price of 833.00 JPY and our intrinsic valuation, Sumitomo Dainippon Pharma Co Ltd (4506.T) is overvalued by 5,049.50%.
Note: result may not be accurate due to the invalid valuation result of DCF model.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (265,628.09) - (22,952.50) | (41,229.71) | -5049.5% |
| DCF (Growth 10y) | (25,018.17) - (282,753.68) | (44,461.93) | -5437.6% |
| DCF (EBITDA 5y) | (6,788.57) - (9,226.30) | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | (9,543.57) - (12,797.40) | (1,234.50) | -123450.0% |
| Fair Value | -2,212.14 - -2,212.14 | -2,212.14 | -365.56% |
| P/E | (5,194.10) - (7,185.03) | (6,149.75) | -838.3% |
| EV/EBITDA | (3,856.87) - (3,984.05) | (3,954.70) | -574.8% |
| EPV | (998.06) - (1,140.64) | (1,069.35) | -228.4% |
| DDM - Stable | (7,002.43) - (27,235.30) | (17,118.87) | -2155.1% |
| DDM - Multi | (10,830.06) - (33,620.01) | (16,486.81) | -2079.2% |
| Market Cap (mil) | 331,450.70 |
| Beta | 1.45 |
| Outstanding shares (mil) | 397.90 |
| Enterprise Value (mil) | 620,480.70 |
| Market risk premium | 6.13% |
| Cost of Equity | 6.31% |
| Cost of Debt | 5.50% |
| WACC | 5.03% |